Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check2 days agoChange DetectedNew version entries were added on 2025-11-10 and 2025-11-07, including a new Study Status item. A government funding notice was removed (dated 2025-07-14). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew history entries document additional study record updates (e.g., recruitment status and contacts/locations) on the Record History page. The overall page layout remains unchanged.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a government operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference9%

- Check52 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%

- Check67 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. No other substantive content changes.SummaryDifference0.5%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.5%

Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.